logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
APC/iFluor® 700 Anti-non-human primates/ human CD177 Antibody
MEM-166
MEM-166 is an anti-non-human primates/ human monoclonal antibody that targets the CD177 antigen. CD177 (sometimes referred to as Neutrophil-specifi c antigen 1, PRV1 or NB1gp) is a 60 kD member of the uPAR family that is expressed on the surface of cells like granulocytes. CD177 plays a role in critical cellular pathways, namely, the regulation of integrin-mediated signaling pathway. In addition, it has been associated with vital biological processes such as leukocyte cell-cell adhesion, particularly cell-cell adhesion via plasma-membrane adhesion molecules. In some organisms, CD177 is an enhancer of superoxide anion generation, and is associated with a variety of biologically interesting macromolecules/ligands. CD177 is a relatively rare antibody target, with fewer than 600 publications in the last decade. Even still, CD177 is essential for immunology research, typically serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to APC/iFluor® 700 (ex/em = 685/710 nm).
product image
product image
CatalogSize
Price
Quantity
117701E025 tests
Price
117701E1100 tests
Price
117701E2500 tests
Price
 
Antibody properties

Other namesNB1gp; HNA-2a; NB1; Neutrophil-specifi c antigen 1; PRV1
CloneMEM-166
Hostmouse
IsotypeMouse IgG1
Reactivitynon-human primates; human
Spectral properties

Extinction coefficient (cm -1 M -1)
700000
Excitation (nm)651
Emission (nm)710
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on September 24, 2025